Kay Research & Care Center

Completed in 2022 through a $50 million Signet donation, the six‑story Kay Research & Care Center sits at the heart of the St. Jude campus.

KAY Jewelers & St. Jude

Since 1999, KAY Jewelers and our customers have proudly supported St. Jude Children’s Research Hospital®, raising more than $122 million to help make cures possible for kids with cancer.

Building on this legacy of impact, KAY and our parent company, Signet Jewelers, have committed $100 million to further advance lifesaving research, treatment and care for children at St. Jude.

Two St. Jude volunteers hugging
Father of St. Jude patient caring for his son

How Your Donation Helps

Zero Financial Burden for Care
Families never receive a bill from St. Jude for treatment, travel, housing or food—so they can focus on helping their children live.

Increasing Survival Rates
When St. Jude opened in 1962, childhood cancer was considered incurable. Since then, St. Jude has helped push the overall survival rate in the U.S. from 20% to more than 80%.

Helping Children Worldwide
St. Jude cares for some of the world's sickest children regardless of their race, ethnicity, beliefs, or ability to pay.
Donate Now

We Make an Impact: KAY on the St. Jude Campus

Together with our customers, our contributions have made a meaningful impact for patients and families on the St. Jude campus. The KAY Research & Care Center is a six-story tower in the heart of the St. Jude campus that is ushering in a new era of research, education, collaboration, care and treatment for the kids at St. Jude.
KAY Research Center on the St. Jude campus
Children's room in the KAY Research Center
Classroom in the St Jude KAY Research Center
Children's room in the KAY Research Center

Meet Slater

St Jude Patient Slater

Slater was 4 in 2018 when he was diagnosed with neuroblastoma, a pediatric cancer that
develops in certain types of nerve tissue. It was stage IV and spreading. At the time, five-year survival rates for neuroblastoma had been around 50% for a decade.

Slater was referred to St. Jude Children’s Research Hospital®, where he fit the criteria for a clinical trial for patients with newly diagnosed, high-risk neuroblastoma. Using an approach called immunotherapy, this clinical trial aimed to find out if adding a specific antibody to the first rounds of chemotherapy could improve outcomes in children with neuroblastoma by helping the body target and kill the cancer cells. Treatment included chemotherapy, immunotherapy, proton beam radiotherapy and a bone marrow transplant.

Now in middle school, Slater attended his first dance, placed second in the science fair and discovered a love of digital media and animation. He likes to cook, play basketball and football, play video games, fish, ski, ice skate and hang out with his older brother, Sawyer.

St. Jude | Kay